“Hopefully, 2014 will be the year of the woman,” says Irwin Goldstein, hardly masking his frustration by the U.S. Food and Drug Administration’s recent rejection of a treatment for female sexual dysfunction.
The Battle Over Female Viagra Ensues
Infertility Options